Andere talen Tianjin Development Holdings Limited

Aandelen

882 HK0882007260

Vertraagde tijd Hong Kong S.E. Andere beurzen 09:22:07 26-04-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
1,72 ^HKD	+0,58%		+6,17%	+17,01%

27/03	Voorzitter Tianjin Development stapt op; opvolger benoemd	MT
27/03	Tianjin Development Holdings Limited kondigt bestuurswisselingen aan	CI

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Tianjin Development’s Chairman Steps Down; Successor Named	27/03
Tianjin Development Holdings Limited Announces Board Changes	27/03
Tianjin Development Holdings Limited Proposes Final Dividend for the Year Ended 31 December 2023, Payable on 29 July 2024	27/03
Tianjin Development Holdings Limited Reports Earnings Results for the Full Year Ended December 31, 2023	27/03
Tianjin Lisheng Pharmaceutical's 2023 Profit Surges on Gains from Asset Disposals; Shares Jump 4%	22/03
Tianjin Development Holdings Expects Up to 80% Jump in 2023 Profit	14/03
Tianjin Development Holdings Limited Provides Consolidated Earnings Guidance for the Year Ended 31 December 2023	13/03
Lisheng Pharmaceutical Buys 65% Stake in Qingchun Kangyuan Pharmaceutical for 137 Million Yuan; Shares Up 3%	02/01
Tianjin Arm Lisheng Pharmaceutical To Buy Chinese Medicine Firm Jiangxi Qingchun Kangyuan	14/12
Tianjin Lisheng Pharma Setting Up Venture Capital Fund	12/12
Tianjin Development to Vote Dec. 5 on Lisheng Pharma's Sale of Tianjin Pharmaceutical Finance Stake	10/11
Tianjin Development Holdings Limited Announces Board Changes	29-09-23
Tianjin Development Holdings Limited(SEHK:882) dropped from S&P Global BMI Index	18-09-23
Tianjin Development Holdings' H1 Attributable Profit Grows	30-08-23
Tianjin Development Holdings Limited Declares Interim Dividend for the Six Months Ended 30 June 2023, Payable on 30 October 2023	30-08-23
Tianjin Development Holdings Limited Reports Earnings Results for the Half Year Ended June 30, 2023	30-08-23
Lisheng Pharmaceutical's H1 Attributable Profit Jumps	25-08-23
China Evergrande sucht Gläubigerschutz in den USA	18-08-23
Lisheng Pharmaceutical Subscribes for 20 Million Yuan Wealth Management Product	02-08-23
Lisheng Pharmaceutical Eyes 247.9 Million Yuan from Potential Land Resumption Deal	26-07-23

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Tianjin Development Holdings Limited

Aandelen

882

HK0882007260

Andere talen

Filters